21Shares XRP ETF (TOXR): Entry into a Material Definitive Agreement
21Shares XRP ETF (TOXR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Benchmark Licensing Agreement On August 20, 2026, 21Shares US LLC (the “Sponsor”) entered into a licensing agreement (the “Benchmark Licensing Agreement”) with FTSE International Limited (“FTSE” or the “Benchmark Provider”). E
How this was made
The 30-second read
Why it matters
The ETF's pricing methodology changes, which may affect NAV and investor sentiment.
Market read
A filing that updates the ETF's benchmark, relevant for traders holding or considering the ETF.
What to watch
Potential fee changes associated with the new licensing agreement.
Background
SEC Form 8‑K filing details a material definitive agreement for the 21Shares XRP ETF.
Ticker impact
21Shares filed an 8‑K reporting a new Benchmark Licensing Agreement to use the FTSE XRP Index for pricing the 21Shares XRP ETF.
Modest impact on ETF price as market adjusts to new benchmark methodology.
The change is operational and does not involve large capital flows, but it updates the ETF's valuation framework.
Market effects
May influence other crypto‑linked ETFs that consider benchmark changes.
Limited to US ETF market; no broader regional effect.
Minimal global impact beyond crypto‑ETF niche.
Counterpoint
The benchmark switch could be seen as a risk if the new index underperforms the previous reference rate.
Key entities
- Sponsor21Shares US LLC
Sponsor of the 21Shares XRP ETF.
- Benchmark ProviderFTSE International Limited
Provider of the FTSE XRP Index used as the new pricing benchmark.
